Cytokinetics | CYTK - Ordinary Share Capital


Cytokinetics reported $122.26M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 169.18M 470K Dec/2025
Amgen USD 539M 1000K Dec/2025
Arca Biopharma USD 48.72M 338K Dec/2025
Bayer EUR 982.42M 0 Dec/2025
Biogen USD 146.7M 200K Sep/2025
Brainstorm Cell Therapeutics USD 11.04M 2K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Capricor Therapeutics USD 57.37M 11.65M Dec/2025
Cytokinetics USD 122.26M 145K Dec/2025
Eisai JPY 282.11M 1000 Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Exelixis USD 268.1M 2.03M Sep/2025
Geron USD 638.36M 338K Dec/2025
Halozyme Therapeutics USD 117.78M 259K Dec/2025
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
Ligand Pharmaceuticals USD 19.66M 19.64M Sep/2025
Merck USD 2.49B 15.79M Sep/2025
Novartis USD 1.91B 10.64M Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025